Envestnet Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.1M Buy
127,964
+26,852
+27% +$3.75M ﹤0.01% 1540
2025
Q4
$16.6M Sell
101,112
-3,123
-3% -$489K ﹤0.01% 1334
2025
Q3
$13.9M Sell
104,235
-1,641
-2% -$199K ﹤0.01% 1542
2025
Q2
$13.2M Sell
105,876
-379
-0.4% -$48.2K ﹤0.01% 1547
2025
Q1
$13.5M Sell
106,255
-187
-0.2% -$28.8K ﹤0.01% 1453
2024
Q4
$15.3M Sell
106,442
-5,809
-5% -$833K ﹤0.01% 1358
2024
Q3
$16.7M Buy
112,251
+3,510
+3% +$503K 0.01% 1299
2024
Q2
$13.7M Buy
108,741
+741
+0.7% +$116K ﹤0.01% 1359
2024
Q1
$19.9M Buy
108,000
+4,079
+4% +$777K 0.01% 1115
2023
Q4
$18.7M Sell
103,921
-2,458
-2% -$383K 0.01% 1071
2023
Q3
$16.9M Buy
106,379
+30,239
+40% +$4.94M 0.01% 1067
2023
Q2
$10.8M Sell
76,140
-304,994
-80% -$48.9M ﹤0.01% 1254
2023
Q1
$8.27M Buy
381,134
+277,271
+267% +$49.5M ﹤0.01% 1346
2022
Q4
$17.6M Sell
103,863
-754
-0.7% -$137K 0.01% 919
2022
Q3
$19.6M Sell
104,617
-623
-0.6% -$131K 0.01% 784
2022
Q2
$17.1M Sell
105,240
-9,388
-8% -$1.48M 0.01% 874
2022
Q1
$21.6M Buy
114,628
+8,122
+8% +$1.54M 0.01% 817
2021
Q4
$28.2M Buy
106,506
+3,679
+4% +$991K 0.01% 694
2021
Q3
$29.7M Buy
102,827
+66,221
+181% +$17M 0.02% 634
2021
Q2
$7.31M Buy
36,606
+5,302
+17% +$1.03M ﹤0.01% 1301
2021
Q1
$6.09M Buy
31,304
+3,481
+13% +$714K ﹤0.01% 1321
2020
Q4
$5.33M Buy
27,823
+1,954
+8% +$356K ﹤0.01% 1251
2020
Q3
$3.82M Buy
25,869
+3,254
+14% +$465K ﹤0.01% 1297
2020
Q2
$2.79M Buy
22,615
+3,465
+18% +$408K ﹤0.01% 1404
2020
Q1
$1.85M Sell
19,150
-1,439
-7% -$139K ﹤0.01% 1464
2019
Q4
$1.9M Buy
20,589
+225
+1% +$18.9K ﹤0.01% 1636
2019
Q3
$1.56M Sell
20,364
-245
-1% -$21.4K ﹤0.01% 1688
2019
Q2
$1.77M Sell
20,609
-305
-1% -$20.8K ﹤0.01% 1626
2019
Q1
$1.24M Buy
20,914
+14,295
+216% +$822K ﹤0.01% 1758
2018
Q4
$349K Buy
+6,619
New +$388K ﹤0.01% 2350
2018
Q3
Sell
-8,021
Closed -$377K 2306
2018
Q2
$377K Buy
8,021
+1,891
+31% +$77.8K ﹤0.01% 1425
2018
Q1
$222K Buy
6,130
+1,002
+20% +$35.2K ﹤0.01% 1539
2017
Q4
$186K Sell
5,128
-950
-16% -$34.4K ﹤0.01% 1876
2017
Q3
$233K Sell
6,078
-1,243
-17% -$52.1K ﹤0.01% 1768
2017
Q2
$303K Buy
7,321
+239
+3% +$9.08K ﹤0.01% 1715
2017
Q1
$249K Buy
7,082
+694
+11% +$22K ﹤0.01% 1830
2016
Q4
$197K Buy
6,388
+223
+4% +$6.9K ﹤0.01% 1899
2016
Q3
$186K Buy
6,165
+629
+11% +$19K ﹤0.01% 2047
2016
Q2
$151K Buy
5,536
+9
+0.2% +$230 ﹤0.01% 2242
2016
Q1
$148K Buy
5,527
+2,377
+75% +$58.2K ﹤0.01% 2228
2015
Q4
$89K Buy
3,150
+1,469
+87% +$42.4K ﹤0.01% 2421
2015
Q3
$47K Buy
+1,681
New +$60.7K ﹤0.01% 2685

Other funds holding RGEN

Envestnet Asset Management's RGEN Position: Q1 2026 in Review

Envestnet Asset Management increased its Repligen (RGEN) stake by 27% in Q1 2026, buying an estimated $3.75M and bringing the position to 127,964 shares worth $15.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

Envestnet Asset Management first reported a position in RGEN in Q3 2015 and has held it in 42 quarters since. The position peaked at $29.7M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Envestnet Asset Management held 127,964 shares of Repligen worth $15.1M as of Q1 2026.
  • Envestnet Asset Management bought 26,852 Repligen shares in Q1 2026, an estimated $3.75M.
  • Repligen made up ﹤0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #1540 holding.
  • Envestnet Asset Management first reported a position in Repligen in Q3 2015 and has held it in 42 quarters since.
  • Envestnet Asset Management's Repligen position peaked at $29.7M in Q3 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.